(Q53194645)

12 May 2018

title

Alzheimer's disease: clinical care and management. (English)

1 reference

12 May 2018

1 reference

Jenike MA

1

1 reference

12 May 2018

publication date

1 June 1986

1 reference

12 May 2018

published in

Psychosomatics

1 reference

12 May 2018

volume

27

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

407-416

1 reference

12 May 2018

Senile dementia of the Alzheimer type

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

1 reference

7 January 2021

Observations on the brains of non-demented old people

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Observations on the brains of demented old people

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Multi-infarct dementia. A cause of mental deterioration in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

A controlled long-term study with ergoloid mesylates (Hydergine) in healthy, elderly volunteers: results after three years

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Ergoloid mesylates for senile dementias: unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Oral physostigmine treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Preliminary Report: Intracranial Cholinergic Drug Infusion in Patients with Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

An overview of pharmacologic treatment of cognitive decline in the aged.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

Management of dementia in the family context

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

The fight against Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2886%2972670-4

7 January 2021

10.1016/S0033-3182(86)72670-4

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018